Pages that link to "Q36482391"
Jump to navigation
Jump to search
The following pages link to Analysis of pharmacokinetic data using parametric models. III. Hypothesis tests and confidence intervals (Q36482391):
Displaying 26 items.
- A double-site absorption model fits to pharmacokinetic data of repaglinide in man. (Q30620757) (← links)
- Population pharmacokinetics. A regulatory perspective. (Q33714243) (← links)
- Adaptive control methods for the dose individualisation of anticancer agents (Q33913894) (← links)
- Statistical analysis of pharmacokinetic data (Q34051009) (← links)
- Pharmacokinetic studies of neuromuscular blocking agents: good clinical research practice (GCRP). (Q34077383) (← links)
- Population pharmacokinetic/pharmacodynamic assessment of pharmacological effect of a selective estrogen receptor β agonist on total testosterone in healthy men. (Q34524636) (← links)
- Ondansetron pharmacokinetics in pregnant women and neonates: towards a new treatment for neonatal abstinence syndrome (Q35075945) (← links)
- Factors influencing elimination and distribution of fleroxacin: metaanalysis of individual data from 10 pharmacokinetic studies (Q35122861) (← links)
- Population pharmacokinetics of platinum after nedaplatin administration and model validation in adult patients (Q35825455) (← links)
- The effect of sepsis upon gentamicin pharmacokinetics in neonates. (Q35827298) (← links)
- Are population pharmacokinetic and/or pharmacodynamic models adequately evaluated? A survey of the literature from 2002 to 2004. (Q36747438) (← links)
- Fundamentals of population pharmacokinetic modelling: validation methods (Q38026590) (← links)
- Pharmacometric Modeling of Liver Metastases' Diameter, Volume, and Density and Their Relation to Clinical Outcome in Imatinib-Treated Patients With Gastrointestinal Stromal Tumors (Q38852974) (← links)
- Improving the estimation of parameter uncertainty distributions in nonlinear mixed effects models using sampling importance resampling (Q39300554) (← links)
- dOFV distributions: a new diagnostic for the adequacy of parameter uncertainty in nonlinear mixed-effects models applied to the bootstrap (Q39300563) (← links)
- Statistical considerations in pharmacokinetic study design (Q40913170) (← links)
- Steady-state population pharmacokinetics of sustained release theophylline in adult asthmatic patients (Q41147463) (← links)
- Saturable rate of cefatrizine absorption after oral administration to humans (Q41228295) (← links)
- Population pharmacokinetics of acyclovir in children and young people with malignancy after administration of intravenous acyclovir or oral valacyclovir. (Q42286838) (← links)
- A quantitative enterohepatic circulation model: development and evaluation with tesofensine and meloxicam (Q43286397) (← links)
- Population pharmacokinetic modeling of steady state carbamazepine clearance in children, adolescents, and adults (Q43544749) (← links)
- Pharmacodynamic comparison of LY3023703, a novel microsomal prostaglandin e synthase 1 inhibitor, with celecoxib (Q47569669) (← links)
- Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies (Q51909775) (← links)
- The modulation of oxygen toxicity by intermittent exposure (Q68318467) (← links)
- Application of optimal sampling theory to the determination of metacycline pharmacokinetic parameters: effect of model misspecification (Q72394153) (← links)
- Cefixime absorption kinetics after oral administration to humans (Q73567827) (← links)